Geode Capital Management, LLC Scopus Bio Pharma Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.36 - $0.74 $4,778 - $9,822	13,273 Added 6.51%	217,078 $93,000
Q1 2022 May 13, 2022	BUY	$0.6 - $1.7 $82,610 - $234,062	137,684 Added 208.23%	203,805 $140,000
Q4 2021 Feb 11, 2022	BUY	$1.63 - $4.28 $107,777 - $282,997	66,121 New	66,121 $108,000
Q2 2021 Aug 13, 2021	SELL	$5.17 - $10.25 $269,662 - $534,629	-52,159 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$7.94 - $14.87 $414,142 - $775,604	52,159 New	52,159 $440,000

100

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.